SUSPENDED FORM

Hereditary Colorectal Cancer Research
Highlights from 2013 - 2014

Presented by Michael Hall, MD, MS - Fox Chase Cancer Center and Deb Neklason, PhD - University of Utah Huntsman Cancer Institute

Please provide your first and last name.

Please provide your email address in order to receive the correct answers and CEUs (if you applied for them).

The following questions are true or false.

1. POLE/POLD1 participates in mismatch and base excision repair pathways.

True False

2. POLE/POLD is suspected to cause extracolonic cancers in the endometrium, ovaries, and brain.

True False

3. EPCAM mutations account for 98% of Lynch Syndrome cases.

True False

4. Sulindac, Tamoxifen, and Imatinib are potential therapies for desmoid tumors.

True False

5. A pre-counseling survey can NOT help facilitate discussions and can NOT lead to lower worry and distress among patients.

True False

6. Please rate your level of satisfaction with the webinar's success in preparing you to achieve the following learning objectives:

Review recent hereditary colorectal cancer research highlights.

Recognize the potential clinical implications of recent research advances.

Be able to relate research advances to current research directions.

7. What is the likelihood that you or someone on your team will:

Use the webinar as a resource in the future?

Refer the webinar to a colleague or patient?

Attend another webinar hosted by the Hereditary Colon Cancer Foundation?

Visit HCCTakesGuts.org to use/share resources for patients and medical professionals?

Please provide any feedback to the host, including any suggestions you have for future webinar topics.